Molecular Cancer Research Targeting the PI3-Kinase Pathway in Cancer Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1541-7786.MCR-06-0150v1
4/7/423    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koumenis, C.
Right arrow Articles by Wouters, B. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koumenis, C.
Right arrow Articles by Wouters, B. G.
Related Collections
Right arrow Cellular Pathobiology
Right arrow Cellular Pathobiology: DNA Damage and Stress Responses
Molecular Cancer Research 4:423-436 (2006)
© 2006 American Association for Cancer Research


Subject Review

"Translating" Tumor Hypoxia: Unfolded Protein Response (UPR)–Dependent and UPR-Independent Pathways

Constantinos Koumenis1 and Bradly G. Wouters2

1 Departments of Radiation Oncology, Cancer Biology, and Neurosurgery, Wake Forest University School of Medicine, Winston-Salem, North Carolina and 2 Department of Radiation Oncology, Maastricht Radiation Oncology (Maastro) Laboratory, GROW Research Institute, University of Maastricht, Maastricht, the Netherlands

Requests for reprints: Bradly G. Wouters, Department of Radiation Oncology, Maastricht Radiation Oncology (Maastro) Laboratory, GROW Research Institute, USN50/23 University of Maastricht, P.O. Box 616, 6200MD Maastricht, the Netherlands. Phone: 31-43-3882912; Fax: 31-43-3884540. E-mail: brad.wouters{at}maastro.unimaas.nl or Contantinos Koumenis, Department of Radiation Oncology, NRC, Room 411, Wake Forest University School of Medicine, Medical Center Blvd., Winston-Salem, NC 27157. Phone: 336-713-7637; Fax: 336-713-7639. E-mail: ckoumen{at}wfubmc.edu

Abstract

Poor oxygenation (hypoxia) is present in the majority of human tumors and is associated with poor prognosis due to the protection it affords to radiotherapy and chemotherapy. Hypoxia also elicits multiple cellular response pathways that alter gene expression and affect tumor progression, including two recently identified separate pathways that strongly suppress the rates of mRNA translation during hypoxia. The first pathway is activated extremely rapidly and is mediated by phosphorylation and inhibition of the eukaryotic initiation factor 2{alpha}. Phosphorylation of this factor occurs as part of a coordinated endoplasmic reticulum stress response program known as the unfolded protein response and activation of this program is required for hypoxic cell survival and tumor growth. Translation during hypoxia is also inhibited through the inactivation of a second eukaryotic initiation complex, eukaryotic initiation factor 4F. At least part of this inhibition is mediated through a Redd1 and tuberous sclerosis complex 1/2–dependent inhibition of the mammalian target of rapamycin kinase. Inhibition of mRNA translation is hypothesized to affect the cellular tolerance to hypoxia in part by promoting energy homeostasis. However, regulation of translation also results in a specific increase in the synthesis of a subset of hypoxia-induced proteins. Consequently, both arms of translational control during hypoxia influence gene expression and phenotype. These hypoxic response pathways show differential activation requirements that are dependent on the level of oxygenation and duration of hypoxia and are themselves highly dynamic. Thus, the severity and duration of hypoxia can lead to different biological and therapeutic consequences. (Mol Cancer Res 2006;4(7):423–36)




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
M. Kraus, E. Malenke, J. Gogel, H. Muller, T. Ruckrich, H. Overkleeft, H. Ovaa, E. Koscielniak, J. T. Hartmann, and C. Driessen
Ritonavir induces endoplasmic reticulum stress and sensitizes sarcoma cells toward bortezomib-induced apoptosis
Mol. Cancer Ther., July 1, 2008; 7(7): 1940 - 1948.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
K. Rantanen, J. Pursiheimo, H. Hogel, V. Himanen, E. Metzen, and P. M. Jaakkola
Prolyl Hydroxylase PHD3 Activates Oxygen-dependent Protein Aggregation
Mol. Biol. Cell, May 1, 2008; 19(5): 2231 - 2240.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Moenner, O. Pluquet, M. Bouchecareilh, and E. Chevet
Integrated Endoplasmic Reticulum Stress Responses in Cancer
Cancer Res., November 15, 2007; 67(22): 10631 - 10634.
[Abstract] [Full Text] [PDF]


Home page
RNAHome page
J. D. Thomas and G. J. Johannes
Identification of mRNAs that continue to associate with polysomes during hypoxia
RNA, July 1, 2007; 13(7): 1116 - 1131.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. D. Blais, C. L. Addison, R. Edge, T. Falls, H. Zhao, K. Wary, C. Koumenis, H. P. Harding, D. Ron, M. Holcik, et al.
Perk-Dependent Translational Regulation Promotes Tumor Cell Adaptation and Angiogenesis in Response to Hypoxic Stress
Mol. Cell. Biol., December 15, 2006; 26(24): 9517 - 9532.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.